Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
FTXHvsTMEDETF Comparison
First Trust Nasdaq Pharmaceuticals ETF (FTXH) and T. Rowe Price Health Care ETF (TMED) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.44% for TMED. FTXH is up 2.6% year-to-date (YTD) with +$7M in YTD flows. TMED performs worse with -0.34% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of FTXH and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
FTXH vs TMED performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH TMED | -2.89%+0.34% | +3.86%+0.27% | +2.60%-0.34% | +22.74%n/a | +39.72%n/a | +37.82%n/a |
| Flows | FTXH TMED | +$4M+$1M | +$9M+$3M | +$7M+$3M | +$10M- | -$13M- | +$7M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH TMED | +15.86%+16.51% | +20.64%n/a | +15.91%n/a | +15.69%n/a |
| Max drawdown | FTXH TMED | -5.21%-7.14% | -16.42%n/a | -19.32%n/a | -19.32%n/a |
| Max drawdown duration | FTXH TMED | 11d48d | 165dn/a | 393dn/a | 393dn/a |
FTXH | TMED | |
Last sale 3/13/2026 at 1:30 PM | $33.63 | $28.63 |
| Previous close 03/12/2026 | $33.78 | $28.71 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
FTXH | TMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
FTXH | TMED | |
|---|---|---|
| Last price | $33.63 | $28.63 |
| 1D performance | -0.45% | -0.25% |
| AuM | $28.72 M | $19.23 M |
| E/R | 0.6% | 0.44% |
FTXH | TMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | First Trust | T. Rowe Price |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | - |
| N° of holdings | 49 | 74 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | June 11, 2025 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the FTXH and TMED ETFs performed in 2026?
As of March 12, 2026, FTXH is up 2.6% year-to-date (YTD), while TMED has lost -0.34%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: FTXH or TMED?
Year-to-date, the FTXH ETF saw +$7M in flows, compared to +$3M for TMED.
Which ETF is bigger: FTXH or TMED?
As of March 12, 2026, FTXH holds $28.72 M in assets under management (AUM), while TMED manages $19.23 M.
What sectors do the FTXH and TMED ETFs invest in?
FTXH leans toward sectors like Health Care. Meanwhile, TMED focuses on Health Care.
What are the top holdings of the FTXH ETF and TMED ETF?
FTXH top holdings include MERCK & CO INC, JOHNSON&JOHNSON and BRISTOL-MYERS SQUIBB. TMED holds in its top three: LILLY, UNITEDHEALTH GRP and GILEAD SCIENCES.
Which ETF is more diversified: FTXH or TMED?
FTXH holds 50 securities with 71.63% of its assets in the top 15. TMED has 80 securities and a top 15 weight of 56.46%.
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
